The cost effectiveness of orthopaedic surgery has long been established for many procedures such as hip and knee replacements. However, navigating through various competing suppliers, alloy combinations and cup and stem sizes, can be a difficult task when investing in your health care system.
HEC NZ has used national and international data and literature to establish cost-effectiveness models stratified by a number of aspects including supplier, alloy combination, prosthesis size and age, BMI and ethnicity of recipient.
With an aging population across several OECD countries, the prevalence and social and economic impact of glaucoma is expected to increase in the coming years. Glaucoma is primarily managed with prescription eye drops; however, today’s advanced technologies and procedures make it possible to diagnose and successfully manage this progressive disease.
HEC NZ has used national and international literature to establish cost-effectiveness models for new and novel technologies in the ophthalmologic space.